FDA Inspection
Senores PharmaceuticalsSenores Pharmaceuticals – FDA Inspection, Mar 28, 2025
Record Details
This FDA Inspection record concerns Senores Pharmaceuticals, with an inspection on March 28, 2025, issued by the Atlanta District Office, covering human drugs.
View Company Profile
ID · c0578cf6-2efc-4014-9aa6-6169353c37f8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1265193
- FDA center
- Human Drugs
- Project area
- Postmarketing Surveillance and Epidemiology: Human Drugs
FDA Citations
2- 21 CFR 314.80(c)(2)Late submission of annual safety reports
- 21 CFR 314.80(c)(2)Late submission of quarterly safety reports
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.